Piramal Pharma Ltd Half Yearly Results

Gross Sales

3,977.43

4,958.29

4,192.89

4,510.93

3,660.23

Excise Duty

0

0

0

0

0

Net Sales

3,977.43

4,958.29

4,192.89

4,510.93

3,660.23

Other Operating Income

0

0

0

0

0

Other Income

178.1

87.43

120.31

113.88

121

Total Income

4,155.53

5,045.72

4,313.2

4,624.81

3,781.23

Total Expenditure

3,712.04

4,059.56

3,646.79

3,775.42

3,262.27

PBIDT

443.49

986.16

666.41

849.39

518.96

Interest

168.57

206.99

214.6

220.1

228.39

PBDT

274.92

779.17

451.81

629.29

290.57

Depreciation

400.12

439.57

376.77

382.45

358.12

Minority Interest Before NP

0

0

0

0

0

Tax

89.56

165.79

144.33

134.3

51.05

Deferred Tax

-33.84

16.63

-3.24

1.16

-25.04

Reported Profit After Tax

-180.92

157.18

-66.05

111.38

-93.56

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-180.92

157.18

-66.05

111.38

-93.56

Extra-ordinary Items

5.9

0

0

-62.79

0

Adjusted Profit After Extra-ordinary item

-186.82

157.18

-66.05

174.17

-93.56

EPS (Unit Curr.)

-1.37

1.19

-0.5

0.84

-0.75

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

1,325.52

1,324.35

1,323.14

1,322.95

1,322.95

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.15

19.88

15.89

18.82

14.17

PBDTM(%)

-

-

-

-

-

PATM(%)

-4.54

3.17

-1.57

2.46

-2.55